SEC Comment Letter for ENDOCARDIAL SOLUTIONS INC (CIK 0000940659) — Jan 13, 2005
ENDOCARDIAL SOLUTIONS INC (CIK 0000940659)
Date: Jan. 13, 2005 · CIK: 0000940659 · Accession: 0000000000-05-002439
AI Filing Summary & Sentiment
File numbers found in text: 000-22233
Letter
Re: Endocardial Solutions, Inc. Preliminary Schedule 14A filed October 19, 2004 File No. 000-22233 Return of Supplemental Information Dear Mr. Kuhns: In response to your request dated January 4, 2005, and pursuant to Rule 12b-4 of the Securities Exchange Act of 1934, enclosed are the following items of supplemental information that were previously furnished to us in connection with our review of the above- referenced filing: * Presentation materials dated August 23, 2004, September 16, 2004 and September 23, 2004 provided by Piper Jaffray & Co. to the board of directors of Endocardial Solutions. As required by Rule 12b-4 of the Exchange Act, a determination has been made that the return of this information is consistent with the provisions of the Freedom of Information Act. Please note, however, that such a determination does not constitute a finding that confidential treatment is appropriate for this information. Please further note that, where it is deemed appropriate, we or the Commission may request that all or a portion of this information be furnished to us again in the future. Please contact Eduardo Aleman at (202) 824-5661 or the undersigned at (202) 942-7924 with any questions about this letter. Sincerely,
January 13, 2005
Mail Stop 03-06
Mr. Robert A. Kuhns, Esq. Dorsey & Whitney LLP 50 South Sixth Street Suite 1500 Minneapolis, Minnesota 55402-1498
David Ritenour Special Counsel ??
??
??
??
[Name of Addressee] [Name of Registrant/Counsel] Page 1
Show Raw Text
<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
January 13, 2005
Mail Stop 03-06
Mr. Robert A. Kuhns, Esq.
Dorsey & Whitney LLP
50 South Sixth Street
Suite 1500
Minneapolis, Minnesota 55402-1498
Re: Endocardial Solutions, Inc.
Preliminary Schedule 14A filed October 19, 2004
File No. 000-22233
Return of Supplemental Information
Dear Mr. Kuhns:
In response to your request dated January 4, 2005, and
pursuant
to Rule 12b-4 of the Securities Exchange Act of 1934, enclosed are
the following items of supplemental information that were
previously
furnished to us in connection with our review of the above-
referenced
filing:
* Presentation materials dated August 23, 2004, September 16, 2004
and September 23, 2004 provided by Piper Jaffray & Co. to the
board
of directors of Endocardial Solutions.
As required by Rule 12b-4 of the Exchange Act, a
determination
has been made that the return of this information is consistent
with
the provisions of the Freedom of Information Act. Please note,
however, that such a determination does not constitute a finding
that
confidential treatment is appropriate for this information.
Please further note that, where it is deemed appropriate, we
or
the Commission may request that all or a portion of this
information
be furnished to us again in the future.
Please contact Eduardo Aleman at (202) 824-5661 or the
undersigned at (202) 942-7924 with any questions about this
letter.
Sincerely,
David Ritenour
Special Counsel
??
??
??
??
[Name of Addressee]
[Name of Registrant/Counsel]
Page 1
</TEXT>
</DOCUMENT>